Total Score: 820/2,100 points (39.0% of maximum possible score)
The TRANQ Research Act of 2023 aims to support research into the impacts and mitigation of xylazine (also known as “tranq”) and its effects on public health. This Act involves moderate increases in government spending and regulatory measures to enhance support for research initiatives. It expands government oversight and funding while having a limited impact on personal freedoms and the free market.
| Criteria | Score (out of 100) | Comments |
|---|---|---|
| 1. Regulatory Language and New Powers | 70 | Grants new responsibilities to the government to support and oversee research into xylazine. |
| 2. Mandates on Individuals or Businesses | 50 | Imposes requirements on research institutions and healthcare providers. |
| 3. Repeal or Modification of Existing Laws | 40 | Modifies existing laws to facilitate research and regulation of xylazine. |
| 4. Funding Provisions and Government Control | 75 | Allocates significant funding for research and mitigation efforts. |
| 5. Powers Granted to Government Agencies | 65 | Grants discretionary powers to agencies overseeing the research initiatives. |
| 6. Penalties and Compliance Mechanisms | 55 | Specifies penalties for non-compliance with new regulations. |
| 7. Reporting Requirements | 60 | Introduces new reporting requirements for research institutions and healthcare providers. |
| 8. Sunset Clauses | 25 | Includes sunset clauses for periodic review of the research initiatives. |
| 9. Authority and Oversight | 65 | Delegates authority to federal agencies to ensure compliance with the Act. |
| 10. Judicial Review | 45 | Provides provisions for judicial review of regulatory decisions. |
| 11. Emergency Powers | 35 | Grants minimal emergency powers related to healthcare and research. |
| 12. Exemptions and Waivers | 35 | Offers limited exemptions from existing regulations. |
| 13. Impact Assessments | 50 | Includes assessments of the expected effects on government control and cost. |
| 14. Spending and Taxes | 70 | Increases government spending to fund the research initiatives. |
| 15. Market Manipulation | 30 | Minor impact on the market through healthcare and research incentives. |
| 16. Tax Code and Reporting | 25 | Minimal impact on the tax code. |
| 17. Areas Outside Original Purpose | 20 | Stays within the original purpose of supporting research into xylazine. |
| 18. Reducing Government Power | 35 | Moderately increases government power through oversight and funding. |
| 19. Impact on Free Markets | 40 | Some impact on free markets due to increased oversight and funding. |
| 20. Personal Freedom | 45 | Enhances personal freedoms related to healthcare and benefits for affected individuals. |
| 21. Reducing Spending and Debt | 30 | Increases spending without addressing the national debt. |